Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.
Neuro Oncol
; 25(6): 1113-1122, 2023 06 02.
Article
in En
| MEDLINE
| ID: mdl-36455228
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Glioblastoma
/
Glioma
Limits:
Humans
Language:
En
Journal:
Neuro Oncol
Journal subject:
NEOPLASIAS
/
NEUROLOGIA
Year:
2023
Type:
Article
Affiliation country:
Spain